Uute Scientific
Uute Scientific was co-founded in 2019 by six researchers including CEO Kari Sinivuori, CSO Oliver Boldt, and professors Heikki Hyöty (Tampere University) and Aki Sinkkonen (University of Helsinki), who led the original ADELE (Autoimmune Defense and Living Environment) research project that started in 2015. The company produces Re-Connecting Nature (RCN), a patented microbial extract sourced from Finnish forest soil containing thousands of microbial species. Unlike conventional probiotic products that contain one or a few species, RCN replicates the full microbial diversity of a natural environment. The extract is scientifically proven to restore skin microbiome balance, strengthen the skin barrier, reduce inflammation, and support the immune system. A 142-participant clinical study published in October 2024 demonstrated that atopic dermatitis patients using RCN cream needed significantly less atopy medication. RCN is integrated into approximately 100 beauty and health products across 10 countries by 35 brands including NOBE Nordic Beauty, Luonkos, Moi Forest, Sees, Õrn Kuu (UK), and Doggy Potion (animal care). The company operates from Helsinki and Lohja, Finland with approximately 9-13 employees.
This is how we approached it and reached the numbers
RCN is present in products across 10 countries through 35 brand partners, including UK (Õrn Kuu), Germany (Harke Chemicals), Sweden (NOBE launch 2024), and Thailand (Doggy Potion). However, all operations, manufacturing, and team remain in Finland. No international offices or dedicated sales presence abroad. International reach is achieved through partner brands, not direct commercial infrastructure.
35 brand partners integrating RCN into approximately 100 products. Revenue is undisclosed but the company has 9-13 employees, €1.5M-$4.2M total funding (sources vary), and enterprise value of €1-2M (Dealroom). The ingredient supply model generates revenue but at early-stage volumes. No indication of profitability or self-sustaining commercial engine yet.
Patented microbial extract containing thousands of species (vs single-species probiotic competitors). University spin-out from a decade of peer-reviewed ADELE research at Helsinki and Tampere universities. Two founding professors (Hyöty, Sinkkonen) provide direct academic IP lineage. 142-participant clinical study (Oct 2024) demonstrating efficacy in atopic dermatitis, a first for this type of microbial intervention. In-vitro studies showing reduced pro-inflammatory cytokines. IP filings confirmed. Not 100 because the product is a single ingredient extract rather than a therapeutic platform, and the company has not yet entered pharmaceutical regulatory pathways.
B2B ingredient supplier to consumer brands across skincare, textiles, toys, and animal care in 10 countries. Scalable model where the ingredient integrates into partner products across multiple categories. Revenue dependent on partner brands' ability to sell through to consumers. Low revenue per brand partner at current scale. IPO ambitions mentioned but not executed. Potential expansion into pharmaceutical applications (CEO quotes reference medicine as future direction) would transform the model but remains aspirational.
Uute Scientific is commercializing a decade of university research that no one else has replicated. The ADELE project at Helsinki and Tampere universities spent years proving that microbial exposure from natural environments protects against immune-mediated diseases. In 2019, six researchers including two university professors spun out to build a company around the finding. The result is Re-Connecting Nature, a patented microbial extract from Finnish forest soil containing thousands of species, integrated into approximately 100 products across 10 countries by 35 brand partners. A 142-participant clinical study published in October 2024 showed that atopic dermatitis patients using the extract needed significantly less medication, the first time adding natural microbial diversity through a cream has positively affected a specific condition. The company is small: under 15 people, operating entirely from Finland, with total funding between €1.5M and $4.2M depending on the source. But the IP is patented, the science is published and peer-reviewed, the product category (microbiome-restoring ingredients) is at the start of a structural growth curve, and the competitive moat is the research itself. Uute Scientific is a deep-tech biotech from the Nordics in the truest sense: real science, real IP, real product in market, and a category it is defining.